Diagnostic approach and therapy of overgrowth and tall stature in childhood;Inquadramento diagnostico e terapia delle condizioni di crescita eccessiva in età pediatrica

Minerva Pediatrica

Volumn 55, Issue 6, 2003, Pages 563-582

  Iughetti, L ^a,d   Bergomi, A ^b   Bernasconi, S ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Pavullo Hospital   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Child; Child development; Growth disorders, diagnosis; Growth disorders, therapy

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RECEPTOR; ESTROGEN; ETHINYLESTRADIOL; GROWTH HORMONE; GROWTH HORMONE DERIVATIVE; SOMATOSTATIN DERIVATIVE; TESTOSTERONE;

ALGORITHM; BECKWITH WIEDEMANN SYNDROME; BODY HEIGHT; BONE AGE; CHILD GROWTH; CLINICAL EXAMINATION; GROWTH DISORDER; GROWTH RATE; HORMONAL THERAPY; HUMAN; KLINEFELTER SYNDROME; PATHOPHYSIOLOGY; REVIEW; SIMPSON GOLABI BEHMEL SYNDROME; SOTOS SYNDROME; SYNDROME DELINEATION; TALL STATURE; TREATMENT PLANNING;

CHILD; FEMALE; GIGANTISM; HUMANS; MALE;

EID: 0842306874     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Hughes JM, Li L, Chinn S, Rona RJ. Trends in growth in England and in Scotland. Arch Dis Child 1997; 76:182-9.
2. Chinn S, Hughes JM, Rona RJ. Trends in growth and obesity in ethnic groups in Britain. Arch Dis Child 1998;78:513-7.
3. Freedman DS, Khan LK, Serdula MK, Srinivasan SR, Berenson GB. Secular trends in children among 2-decades: the Bogalusa Heart Study. Arch Pediatr Adolesc Med 2000;154:155-61.
4. Sotos JF. Overgrowth. Section I-VI. Clin Pediatr October 1996-March 1997.
5. Weaver DD. Overgrowth syndromes and disorders: definition, classification and discussion. GROWTH Genetics and Hormones vol.10 No.1 March 1994.
6. Shanske, AL, Bogdanow A, Shprintzen BJ, Marion RW. The Marshall syndrome: report of a new family and review of the literature. Am J Med Genet 1997;70:52-7.
7. rd ed. Oxford: Oxford University Press; 1990.p.323-52.
8. David TJ, Webb BW, Gordon IR. The Patterson syndrome, leprechaunism and pseudoleprechaunism. J Med Genet 1981;18:294-8.
9. Beighton P. Inherited disorders of the skeleton. New York: Churchill Livingstone; 1988.p.454-73.
10. Cohen MM. Perspectives on overgrowth syndromes. Am J Med Genet 1998;79:234-7.
11. Ivanovich J, Mallory S, Storer T, Ciske D, Hing A. Twelve-year-old male with Elejalde syndrome (neuroectodermal melanolysosomal disease). Am J Med Genet 2001;98:313-6.
12. Dickerman Z, Loewinger J, Laron Z. The pattern of growth in children with constitutional tall stature from birth to age 9 years. A longitudinal study. Acta Paediatr Scand 1984;S73:530-6.
13. Rosenfield RL. Essentials of growth diagnosis. Endocrinol Metab North Am 1996;25:754-7.
14. Tuddenhan RD, Snyder MM. Physical growth of California boys and girls from birth to 18 years. Berkley: UC Press; 1954.
15. Eugster EA, Pescovitz OH. Gigantism. J Clin Endocrinol Metab 1999;84:4379-84.
16. Drop SL, De Waal WJ, De Muinck Keinzer-Schrama SMPF. Sex steroid treatment of constitutional tall stature. Endocr Rev 1998;19:540-58.
17. Holl RW, Bucher P, Sorgo W, Heinze E, Homoki J, Debatin KM. Suppression of GH by oral glucose in the evaluation of tall stature. Horm Res 1999;51:20-4.
18. Spiegel AM. Aspects of G-protein signalling in health and disease. In: O'Rahilly S, Dunger D, editors. Genetic insights in paediatric endocrinology and metabolism. Bristol: BioScientifica Ltd; 1999.
19. Agwu JC, Shaw NJ, Kirk J, Chapman S, Ravine D, Cole TRP. Growth in Sotos syndrome. Arch Dis Child 1999;80:339-42.
20. Opitz JM, Weaver DW, Reynolds JF. The syndromes of Sotos and Weaver: reports and review. Am J Med Genet 1998;79:294-304.
21. Lam WWK, Maher ER. Beckwith-Wiedemann syndrome. Current Paediatrics 1998;8:117-20.
22. Maher ER. Beckwith-Wiedemann syndrome. In: O'Rahilly S, Dunger D, editors. Genetic insights in paediatric endocrinology and metabolism. Bristol: Bio-Scientifica Ltd; 1999.
23. Elliott M, Bayly R, Cole TRP, Temple K, Maher ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin Genet 1994;46:168-74.
24. Verloes A, Massart B, Dehalleux I, Langhendries JP, Koulischer L. Clinical overlap of Beckwith-Wiedemann, Periman and Simpson-Golabi-Behmel syndromes: a diagnostic pitfall. Clin Genet 1995;47:257-62.
25. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 1996;12:241-7.
26. Clark AJL, Weber A. Adrenocorticotropin insensitivity syndromes. Endocr Rev 1998;19:828-43.
27. Slavotinek AM, Hurst JA, Dunger D, Wilkie AO. ACTH receptor mutation in a girl with familial glucocorticoid deficiency. Clin Genet 1998;53:57-62.
28. Weber A, Toppari J, Harvey RP, Klann RC, Shaw NJ, Ricker AT et al. Adrenocorticotropin receptor gene mutations in familial glucocorticoid deficiency: relationships with clinical features in 4 families. J Clin Endocrinol Metab 1995;80:65-71.
29. Grant DB, Barnes ND, Moncrieff MW, Savage M. Clinical presentation, growth and pubertal development in Addison's disease. Arch Dis Child 1985;60:925-8.
30. Moller DE, Flier JS. Insulin resistance mechanism, syndromes and implications. N Engl J Med 1991;325:938-48.
31. DePaepe A, Devrewx RB, Dietz H, Henekam R, Pyentz R. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417-26.
32. Topalogh AK, Sansaricq C, Snyderman SE. Influence of metabolic control on growth in homocystinuria due to cystathionine B-synthase deficiency. Pediatr Res 2001;49:796-8.
33. Smith EP. Sex steroid actions on epiphyseal maturation: evolving new concepts. Clin Pediatr Endocrinol 1997;6Suppl 9:1-6.
34. Smith ED, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-61.
35. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ERI. A syndrome of female pseudo-hermaphroditism, hypergonadotropic hypogonadism and multicystic ovaries associated with missense mutations in the gene encoding aromatase. J Clin Endocrinol Metab 1994;78: 1287-92.
36. Morishima A, Grumbach MM, Simpson ER, Fisher C, Oin KI. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80: 3689-98.
37. Klein KO, Baron J, Colli MJ, McDonnel DP, Cutler GB. Oestrogen levels in childhood determined by an ultra-sensitive recombinant cell bioassay. J Clin Invest 1994; 94:2475-80.
38. Klein KO, Marta PM jr, Blizzard RM, Herbst T, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay. J Clin Endocrinol Metab 1996;81:3203-7.
39. Tanner JM, Whitehouse RM, Hughes PC, Carter PS. Relative importance of growth hormone and sex steroid for the growth at puberty of trunk length, limb length, and muscle width in growth hormone deficient children. J Pediatr 1976;89:1000-8.
40. Uriarte MM, Baron J, Garcia HB, Barnes KM, Loriaux DL, Cutler JB jr. The effect of pubertal delay on adult height in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1992;74:436-40.
41. Frank GR. The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of skeleton. Acta Paediatr 1996;84:627-30.
42. Federman DD. Life without estrogen. N Engl J Med 1994;331:1088-9.
43. Werder EA, Waibel P, Sege D, Flury R. Severe thrombosis during oestrogen treatment for tall stature. Eur J Pediatr 1990;149:389-90.
44. Weimann F, Borgmann S, Botiles HJ. Oestrogen treatment of constitutional tall stature. A risk-benefit ratio. Arch Dis Child 1998;78:148-51.
45. Brook CGD, Stanhope R, Preece MA, Aynsley Green A, Hindmarsh PC. Oestrogen treatment of tall stature. Arch Dis Child 1998;79:198.
46. Bramswig JH, von Lengerke HJ, Schmidt H, Schellong J. The result of short-term (6 months) high-dose testosterone treatment on bone age and adult height in boys of excessively tall stature. Eur J Pediatr 1988; 148:104-6.
47. Bettendorf M, Heinrich UE, Schonberg DK, Grulich-Henn J. Short-term high-dose testosterone treatment fails to reduce adult height in boys with constitutional tall stature. Eur J Pediatr 1997;156:911-5.
48. Lee PA, Witchel SF. The influence of estrogen on growth. Curr Opin Pediatr 1997;9:431-6.
49. Aslaken PE, Zachmann M. Body proportions in untreated and treated children with familial tall stature. Acta Med Auxol 1991;23:237-43.
50. Brinkers JM, Lamore PJ, Gevers AF, Boersma B, Wit JM. The effects of oestrogen treatment on body proportions in constitutionally tall girls. Eur J Pediatr 1994;153: 237-40.
51. Joss EE, Zeuner J, Zurbrigg RP, Mullis PE. Impact of different doses of ethinyloestradiol on reduction of final height in constitutionally tall girls. Eur J Pediatr 1994; 153:797-801.
52. Drop SL, Greggio N, Cappa M, Bernasconi S. Current concepts in tall stature and overgrowth syndromes. J Pediatr Endocrinol Metab 2001;14Suppl.2:975-84.
53. Bielicki T, Szklarska A. Are social-class differences in stature partly genetic? A hypothesis revisited. Am J Hum Biol 2000;12:97-101.
54. th Congress of Auxology International Association for Human Auxology - ©Smith-Gordon: London, UK; 1999. p.303-11.